RBMY1F

Across TCGA pan-cancer cohorts, RBMY1F RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RBMY1F data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RBMY1F RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RBMY1F expression acts as an unfavorable survival marker.

LUSC, LAML, and THYM are the cancer types where RBMY1F RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.112	0.664	.012	36	view →
LAML	DFS	Tertile	All	0.027	0.583	<.001	36	view →
THYM	DFS	Tertile	All	0.174	0.759	.028	27	view →
LIHC	DFS	Tertile	All	0.224	0.567	<.001	24	view →
LUAD	OS	Tertile	All	0.439	0.814	.015	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RBMY1F–LUSC (OS)

Open the LUSC breakdown →